After Pfizer Inc announced Wednesday that the Covid vaccine it developed with BioNTech showed 95% efficacy in phase 3 final trial, BioNTech Chief Executive Officer, Ugur Sahin, told Reuters that vaccine deliveries could start before Christmas.
Key Quotes
“If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively.”
“US emergency use authorization (EUA) would be applied for on Friday.”
Market Reaction
S&P 500 futures have shrugged-off the upbeat comments, as fears over the surging COVID cases intensify and dent the appetite for riskier assets. The futures tied to the S&P 500 index drop 0.10% to 3,561, as of writing.
Reprinted from FX Street. The copyright is reserved by the original author.
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。